<?xml version="1.0"?>
<Articles JournalTitle="Case Reports in Clinical Practice">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Case Reports in Clinical Practice</JournalTitle>
      <Issn>2538-2683</Issn>
      <Volume>8</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>09</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Immune Thrombocytopenic Purpura (ITP) As a  Complication of COVID-19: A Case Report</title>
    <FirstPage>143</FirstPage>
    <LastPage>145</LastPage>
    <AuthorList>
      <Author>
        <FirstName>shaghayegh</FirstName>
        <LastName>Ashraf Talesh</LastName>
        <affiliation locale="en_US">Department of Infectious Diseases, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Azar</FirstName>
        <LastName>Hadadi</LastName>
        <affiliation locale="en_US">Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Immune thrombocytopenic purpura (ITP) is a condition that can occur either spontaneously or as a secondary complication of preexisting disorders, often associated with viral infections. In the context of COVID-19, hematological manifestations, including thrombocytopenia, have been observed and linked to increased mortality rates among severely infected patients.Presented here is a case study of a 70-year-old man who recovered from COVID-19 but subsequently developed ITP. The severity of his thrombocytopenia exceeded what is typically observed during COVID-19 infections, leading to a diagnosis of ITP. Treatment with steroids and intravenous immunoglobulin (IVIG) was initiated based on specialist recommendations, resulting in an adequate response.</abstract>
    <web_url>https://crcp.tums.ac.ir/index.php/crcp/article/view/819</web_url>
  </Article>
</Articles>
